Ascentis Independent Advisors Buys 2,942 Shares of Danaher Corporation $DHR

Ascentis Independent Advisors lifted its stake in Danaher Corporation (NYSE:DHR) by 118.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,432 shares of the conglomerate’s stock after buying an additional 2,942 shares during the period. Ascentis Independent Advisors’ holdings in Danaher were worth $1,030,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in DHR. JPL Wealth Management LLC bought a new position in Danaher in the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC bought a new position in shares of Danaher in the 2nd quarter worth about $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its stake in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Weiss Ratings lowered Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, June 29th. UBS Group reduced their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. DZ Bank began coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Wells Fargo & Company cut their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $233.52.

Danaher Trading Up 0.3%

NYSE:DHR opened at $194.17 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $137.42 billion, a PE ratio of 37.56, a PEG ratio of 2.47 and a beta of 0.79. The firm has a 50-day moving average of $179.65 and a 200-day moving average of $199.92.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the business earned $1.88 EPS. The company’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, equities research analysts expect that Danaher Corporation will post 8.44 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.